FreeS Fund Report 15: The Life Gamble — The Risk-Filled Journey of Drug R&D | Frees Fund
The Ideals and Persistence Behind a 3% Success Rate.
Articles
XtalPi Closes $46 Million Series B+ Round | FreeS Fund Deal Brief
Empowering drug R&D organizations worldwide.
Community Group-Buying Platform Linlinyi Raises Tens of Millions of Dollars in Series A Funding Led by Source Code Capital
"Good products, fair prices"
Mining India: Battle-Tested Insights | Code Brain Episode 8
"Code Brain" connects Source Code Capital's entrepreneurs with external experts for private, offline brainstorming sessions.
FreeS Fund Angel-Round Portfolio Company NextVPU Closes 200 Million RMB Series A | FreeS Funding News
We provide professional solutions for robotics, drones, autonomous vehicles, and security surveillance.
Source Code Capital portfolio company GalaxySpace successfully launched its experimental payload!
"Yuqan No. 1"
Another New Retail Unicorn Emerges: FreeS Fund Angel-Round Project Huasheng Haoche Closes $210M Series B | FreeS Funding News
FreeS Fund continued to increase its stake.
Source Code Capital Portfolio Company Cijinrong Announces Completion of Series B Financing, with Existing Investor Source Code Capital Continuing to Increase Stake
Super Loan Officer + Credit Factory + Big Data
Li Feng's Column 13: China Is at Its Most Precious Historical Moment | Frees Fund
Over four decades of turbulence, the darkest days have always given rise to market opportunities.
"Manufacturing-First Retail": The Opportunity and Its Rise | Source Code Capital Internal Briefing
Touch factories and customers with both hands.